To create and edit articles, please register and log-in

User Tools

    To create and edit articles, please register and log-in

Site Tools


Main Menu

Main menu
Click categories to expand


A-Z listingplugin-autotooltip__plain plugin-autotooltip_bigA-Z listing

This is an alphabetical index of all content pages.


Other categories

Utilities

Contacts
Register

Also see

Importance Ratings
News
Legal
Donate/Sponsor


Wikenigma supports:


Feeds etc
rss / xml feed
sitemap file
A-Z listing (archived)


Auto-Translate Site

Wikenigma - an Encyclopedia of Unknowns Wikenigma - an Encyclopedia of the Unknown

Amantadine

Amantadine was originally developed in the mid 1960s as an anti-viral drug used to treat Influenza-A. Now largely withdrawn for use against 'flu due to widespread drug-resistance concerns.

It was subsequently found to be of use in treating the dyskinesia (faulty movements) and rigidity of Parkinson's diseaseplugin-autotooltip__plain plugin-autotooltip_bigParkinson's disease

Also known as Parkinson disease, Parkinson's, idiopathic Parkinsonism, primary Parkinsonism, PD, or paralysis agitans - is a degenerative disorder of the central nervous system resulting from the death of dopamine-containing cells in the
. It's now sold under the brand names Gocovri, Wiregyt, Amanta, Amixx, Inflex, Tregor and others, and often used alongside other drugs such as Levodopa.

The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.

Source : Pubmed


    Share this page :

Dear reader : Do you have any suggestions for the site's content?

Ideas for new topics, and suggested additions / corrections for old ones, are always welcome.

If you have skills or interests in a particular field, and have suggestions for Wikenigma, get in touch !


Or, if you'd like to become a regular contributor . . . request a login password. Registered users can edit the entire content of the site, and also create new pages.

( The 'Notes for contributors' section in the main menu has further information and guidelines etc.)

Automatic Translation

You are currently viewing an auto-translated version of Wikenigma

Please be aware that no automatic translation engines are 100% accurate, and so the auto-translated content will very probably feature errors and omissions.

Nevertheless, Wikenigma hopes that the translated content will help to attract a wider global audience.

Show another (random) article

DOKUWIKI IMPLEMENTATION DESIGN BY UNIV.ORG.UK JANUARY 2022